Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemi...
Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
The purpose of the study was to evaluate the efficacy of preoperative intravenous (IV) ferric carboxymaltose (FCM) administration vs. no-IV iron in colon cancer (CC) anemic patients undergoing elective surgery with curative intention.
Methods
This was a multicenter, observational study including two cohorts of consecutive CC anemic...
Alternative Titles
Full title
Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4773500
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4773500
Other Identifiers
ISSN
0179-1958
E-ISSN
1432-1262
DOI
10.1007/s00384-015-2461-x
